New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are newly emerging insulin-independent anti-hyperglycemic agents that work independently of β-cells. Quite a few large-scale clinical trials have proven the cardiovascular protective function of SGLT2is in both diabetic and non-diabetic patients. B...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Juexing, Zhou, Lei, Gong, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520058/
https://www.ncbi.nlm.nih.gov/pubmed/36186974
http://dx.doi.org/10.3389/fcvm.2022.903902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520058/
https://www.ncbi.nlm.nih.gov/pubmed/36186974
http://dx.doi.org/10.3389/fcvm.2022.903902

Ejemplares similares